SN
1324.76 GBP
-0.88%
Today
-0.54%
1D
Last seen at Tue, 24 Feb 2026 19:14:00 GMT+3
Market is closed
Sun
Closed
Mon
10:01 AM ~ 6:30 PM
Tue
10:01 AM ~ 6:30 PM
Wed
10:01 AM ~ 6:30 PM
Thu
10:01 AM ~ 6:30 PM
Fri
10:01 AM ~ 6:30 PM
Sat
Closed
Performance
1 Day
- 0.54 %
1 Week
+ 1.14 %
1 Month
+ 9.16 %
3 Month
+ 6.60 %
6 Month
- 3.17 %
1 Year
+ 28.11 %
Information
Name
Smith & Nephew Leveraged ( UK )
Currency
GBP
Standard Leverage
3X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0187%
Overnight Fees Sell
0.0020%
Market Cap
10.36B
Avg Daily Volume
2.33M
52 Week High
1441.5 GBP
52 Week Low
937.8 GBP
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01870% | $(0.187) |
| SELLS | 0.00200% | $0.020 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Top News
Smith.Nephew
-0.54%
RBC Capital Raises Price Target on Smith & Nephew (SNN) Ahead of Capital Markets Day
finance.yahoo.com
3mo ago
Smith.Nephew
-0.54%
Moody’s Upgrades Smith & Nephew (SNN) Long-Term Rating, Citing Strong Revenue and Margin Growth
finance.yahoo.com
4mo ago
Smith.Nephew
-0.54%
J&J lays out plan to splinter orthopedics business into separate company
finance.yahoo.com
4mo ago
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
